Literature DB >> 21832991

Calcium cycling proteins and their association with heart failure.

L Hadri1, R J Hajjar.   

Abstract

Heart failure (HF) has reached epidemic proportions in the United States and is one of the most important challenges to public health. Severe congestive HF is associated with substantial morbidity and mortality. HF afflicts approximately 5 million patients and contributes to 3 million hospitalizations and 300,000 deaths yearly. Late-stage HF has a poor prognosis, and therapeutic options are limited. Defective excitation–contraction (EC) coupling in HF may result from altered density or function of proteins relevant for Ca2+ homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832991      PMCID: PMC4475407          DOI: 10.1038/clpt.2011.161

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  40 in total

1.  Type 1 phosphatase, a negative regulator of cardiac function.

Authors:  Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

3.  A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.

Authors:  Kobra Haghighi; Fotis Kolokathis; Anthony O Gramolini; Jason R Waggoner; Luke Pater; Roy A Lynch; Guo-Chang Fan; Dimitris Tsiapras; Rohan R Parekh; Gerald W Dorn; David H MacLennan; Dimitrios Th Kremastinos; Evangelia G Kranias
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 4.  The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.

Authors:  C Communal; W S Colucci
Journal:  Arch Mal Coeur Vaiss       Date:  2005-03

5.  Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven Reiken; John A Vest; Anetta Wronska; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-06       Impact factor: 11.205

6.  Ca2+ cycling and new therapeutic approaches for heart failure.

Authors:  Anne-Marie Lompré; Roger J Hajjar; Sian E Harding; Evangelia G Kranias; Martin J Lohse; Andrew R Marks
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

Review 7.  Cardiac adrenoceptors: physiological and pathophysiological relevance.

Authors:  Otto-Erich Brodde; Heike Bruck; Kirsten Leineweber
Journal:  J Pharmacol Sci       Date:  2006-04-13       Impact factor: 3.337

8.  Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.

Authors:  Tong Zhang; Tao Guo; Shikha Mishra; Nancy D Dalton; Evangelia G Kranias; Kirk L Peterson; Donald M Bers; Joan Heller Brown
Journal:  Circ Res       Date:  2009-12-03       Impact factor: 17.367

9.  Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts.

Authors:  D L Baker; K Hashimoto; I L Grupp; Y Ji; T Reed; E Loukianov; G Grupp; A Bhagwhat; B Hoit; R Walsh; E Marban; M Periasamy
Journal:  Circ Res       Date:  1998 Dec 14-28       Impact factor: 17.367

10.  Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes.

Authors:  Ali El-Armouche; Thomas Rau; Oliver Zolk; Diana Ditz; Torsten Pamminger; Wolfram-H Zimmermann; Elmar Jäckel; Sian E Harding; Peter Boknik; Joachim Neumann; Thomas Eschenhagen
Journal:  FASEB J       Date:  2003-01-02       Impact factor: 5.191

View more
  10 in total

1.  Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.

Authors:  Lahouaria Hadri; Razmig G Kratlian; Ludovic Benard; Bradley A Maron; Peter Dorfmüller; Dennis Ladage; Christophe Guignabert; Kiyotake Ishikawa; Jaume Aguero; Borja Ibanez; Irene C Turnbull; Erik Kohlbrenner; Lifan Liang; Krisztina Zsebo; Marc Humbert; Jean-Sébastien Hulot; Yoshiaki Kawase; Roger J Hajjar; Jane A Leopold
Journal:  Circulation       Date:  2013-06-26       Impact factor: 29.690

2.  S100A1 in human heart failure: lack of recovery following left ventricular assist device support.

Authors:  Mosi K Bennett; Wendy E Sweet; Sara Baicker-McKee; Elizabeth Looney; Kristen Karohl; Maria Mountis; W H Wilson Tang; Randall C Starling; Christine S Moravec
Journal:  Circ Heart Fail       Date:  2014-05-19       Impact factor: 8.790

Review 3.  Arrhythmia-associated cardiac Ca²(+) cycling proteins and gene mutations.

Authors:  Simon Kochhäuser; Eric Schulze-Bahr; Uwe Kirchhefer
Journal:  Wien Med Wochenschr       Date:  2012-06-25

4.  Folic acid reverses nitric oxide synthase uncoupling and prevents cardiac dysfunction in insulin resistance: role of Ca2+/calmodulin-activated protein kinase II.

Authors:  Nathan D Roe; Emily Y He; Zhenbiao Wu; Jun Ren
Journal:  Free Radic Biol Med       Date:  2013-06-29       Impact factor: 7.376

Review 5.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

6.  High-throughput FRET assay yields allosteric SERCA activators.

Authors:  Razvan L Cornea; Simon J Gruber; Elizabeth L Lockamy; Joseph M Muretta; Dongzhu Jin; Jiqiu Chen; Russell Dahl; Tamas Bartfai; Krisztina M Zsebo; Gregory D Gillispie; David D Thomas
Journal:  J Biomol Screen       Date:  2012-08-24

7.  A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum.

Authors:  Tobias Gröβl; Elke Hammer; Sandra Bien-Möller; Anja Geisler; Sandra Pinkert; Carsten Röger; Wolfgang Poller; Jens Kurreck; Uwe Völker; Roland Vetter; Henry Fechner
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

8.  Increased Na⁺/Ca²⁺ exchanger expression/activity constitutes a point of inflection in the progression to heart failure of hypertensive rats.

Authors:  Jesica S Rodriguez; J Omar Velez Rueda; Margarita Salas; Romina Becerra; Mariano N Di Carlo; Matilde Said; Leticia Vittone; Gustavo Rinaldi; Enrique L Portiansky; Cecilia Mundiña-Weilenmann; Julieta Palomeque; Alicia Mattiazzi
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

9.  Luteolin improves cardiac dysfunction in heart failure rats by regulating sarcoplasmic reticulum Ca2+-ATPase 2a.

Authors:  Wenjing Hu; Tongda Xu; Pei Wu; Defeng Pan; Junhong Chen; Jing Chen; Buchun Zhang; Hong Zhu; Dongye Li
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

10.  Mechanical Stretching Simulates Cardiac Physiology and Pathology through Mechanosensor Piezo1.

Authors:  Tzyy-Yue Wong; Wang-Chuan Juang; Chia-Ti Tsai; Ching-Jiunn Tseng; Wen-Hsien Lee; Sheng-Nan Chang; Pei-Wen Cheng
Journal:  J Clin Med       Date:  2018-11-02       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.